Skip to content

Game Ready continuous-flow cryo- and cyclic compression therapy after fracture treament of the hip: a prospective multicenter, open-label, multicenter, randomized, controlled, clinical trial on postoperative effects on pain.

Game Ready continuous-flow cryo- and cyclic compression therapy after fracture treament of the hip: a prospective multicenter, open-label, multicenter, randomized, controlled, clinical trial on postoperative effects on pain. - GRAPES

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41653
Enrollment
160
Registered
2014-09-29
Start date
2014-12-23
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

broken hip hip fracture

Interventions

The only intervention consists of the postoperative application of the Game Ready treatment. This is a commercially available machine which combines cyro- and compression therapy into one. The mach
no pressure, low pressure (5-15 mmHg), medium pressure (5-50 mmHg) and high pressure (5-75 mmHg) The temperature can also be adjusted between 4,0°C and 10,0°C with 3 settings. We will use the lowest

Sponsors

Spaarne Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with intra- or extracapsular hip fracture in need for total hip-, hemiarthroplasty, intramedullary nailing, a dynamic hip screw or canullated screws. - Older than 18 years - Able and willing to give informed consent prior to GRS treatment and randomization.

Exclusion criteria

Exclusion criteria: 1) Fractures at multiple loci 2) Open fracture/skin lacerations/open wounds 3) Acetabular fracture 4) (Suspicion of) concomitant malignancy 5) BMI >40 6) Preoperative osteosynthesis materials in situ in the ipsilateral leg above knee level 7) Unable or unwilling to give informed consent by proxy 8) Morphine allergy or dependence 9) ASA 4 10) Cold hemoglobinuria/cryoglobulinaemia 11) Morbus Raynaud 12) Central neuromuscular disorder 13) Absent distal pulsations in the injured extremity (vascular impairment) 14) Active deep vein thrombosis or suspected pulmonary embolism 15) Patient delay >24 hrs 16) NYHA * 3 17) Only if the clinician has doubts about the cognitive state of the subject can the IQCODE be administered, if the IQCODE score * 4.6 is will the subject be excluded 18) Postoperative hemodynamic instability 19) Use of local anaesthetics (LIA) or long-acting femoral blocks

Design outcomes

Primary

MeasureTime frame
Primairy outcome is 11-point numeric rating scale (NRS painscore) at 24 hours after surgery.

Secondary

MeasureTime frame
- 48 hours postoperative NRS painscore - 72 hours postoperative NRS painscore - Total morphine consumption; measured by recalculating all the administered morphine to one form (e.g. Oramorph) - Postoperative bloodloss measured by hemoglobin values preoperative, at day 1 and day 3 - The necessity for transfusion of erythrocyte concentrate - Admission time (in hours) - Functional outcome at 6 weeks measured by the Timed Up and Go Test and the Morton Mobility Index - Self-assessed health outcome (EQ-5D en SF-12) - Complications (DVT, infection, early aseptic loosening of the prosthesis) - User-friendliness of the GRS - Incidence of delirium and use of psychotropic medication - Rehabilitation location (home/rehabilitation clinic) and duration - Thermodynamic properties of applied therapy (optional)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)